Researchers found that risky patterns of methamphetamine use and the diversity of people who used methamphetamine increased between 2015 and 2019.| National Institutes of Health (NIH)
Methamphetamine is one of the powerful stimulants of the central nervous system (CNS). It is sometimes a second-line treatment for attention deficit hyperactivity disorder and obesity; however, methamphetamine is better known as a recreational drug. This activity will highlight the mechanism of action, adverse event profile/toxicity, pharmacology, monitoring, relevant interactions, and street names of methamphetamine, pertinent for interprofessional team members should they encounter patients...| www.ncbi.nlm.nih.gov
Ch. 11.1: Stimulants and Their Effects | Introduction to Substance Use Disorders
Overdose deaths involving methamphetamine nearly tripled from 2015 to 2019 among people ages 18-64 in the U.S., according to a NIDA study published in JAMA Psychiatry.| NIH Record
Mechanism and Pharmacokinetics| Hospital Handbook
